All news from Anaesthesiology

A Drug Approved Prevents The Growth Of Vestibular Schwannomas

Researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This sometimes-lethal intracranial tumor typically causes hearing loss and tinnitus. They suggest that mifepristone is a promising drug candidate to be repositioned for the treatment of these tumors. The study was published in Scientific Reports.

India’s Healthcare Sector: Solutions to Problems

India’s per capita income has witnessed significant rise from merely ?1,705 in 1960 to ?103,219 in 2016-17. Higher income levels have led to better living conditions and further improved the average Indian’s life expectancy from merely 32 years at independence, lower than even Africa’s average at 38 years, to a commendable 68 years today.

New Proteins Are Responsible For The Functioning Of Bacteria

A study estimates the ability to leach heavy metals from the environment and digest a potent greenhouse gas; methanotrophic bacteria pull double duty when it comes to cleaning up the environment. The researcher has identified two never-before-studied proteins, called MbnB and MbnC, as partially responsible for the bacteria's inner workings. The study was published in the journal Science.

A New Drug Treating Skin Lesions In TSC

Researchers have developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare, intractable disease, a world first. Following the physician-led clinical studies, I and II by Osaka University, Phase III clinical trials by a pharmaceutical company, the drug were approved within six months of the drug application by the SAKIGAKE Designation System. The study was published in JAMA Dermatology.